Literature DB >> 16258457

Participation in cancer trials: recruitment of underserved populations.

Electra D Paskett1, Mira L Katz, Cecilia R DeGraffinreid, Cathy M Tatum.   

Abstract

One approach to address cancer health disparities is to focus on the under-representation by minority populations in cancer trials. Recruitment strategies include: 1) characterizing the target populations, 2) involve members of the population in planning, 3) take the message to the population, 4) give something back to the community, 5) enhance credibility with a community spokesperson, 6) identify and remove barriers, 7) improve staff sensitivity, and 8) educate the population about the trial. To recruit minorities to clinical trials, we have developed the Accrual to Clinical Trials (ACT) framework for understanding and enhancing the recruitment of participants to cancer trials.

Entities:  

Mesh:

Year:  2003        PMID: 16258457

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


  18 in total

1.  Racial Differences Among Factors Associated with Participation in Clinical Research Trials.

Authors:  Anita Kurt; Lauren Semler; Jeanne L Jacoby; Melanie B Johnson; Beth A Careyva; Brian Stello; Timothy Friel; Mark C Knouse; Hope Kincaid; John C Smulian
Journal:  J Racial Ethn Health Disparities       Date:  2016-09-08

2.  Survey of community engagement in NIH-funded research.

Authors:  Nancy E Hood; Tracy Brewer; Rebecca Jackson; Mary Ellen Wewers
Journal:  Clin Transl Sci       Date:  2010-02       Impact factor: 4.689

3.  Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.

Authors:  Grace C Hillyer; Melissa Beauchemin; Dawn L Hershman; Moshe Kelsen; Frances L Brogan; Rossy Sandoval; Karen M Schmitt; Andria Reyes; Mary Beth Terry; Andrew B Lassman; Gary K Schwartz
Journal:  Clin Trials       Date:  2020-02-03       Impact factor: 2.486

4.  Innovative approaches to reducing cancer health disparities: the Moffitt Cancer Center Patient Navigator Research Program.

Authors:  Kristen J Wells; Cathy D Meade; Ercilia Calcano; Ji-Hyun Lee; Desiree Rivers; Richard G Roetzheim
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

5.  Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials.

Authors:  George M Ibrahim; Caroline Chung; Mark Bernstein
Journal:  J Neurooncol       Date:  2011-02-12       Impact factor: 4.130

6.  Patient internet use surrounding cancer clinical trials: clinician perceptions and responses.

Authors:  Christian Simon; Sarah Schramm; Stephen Hillis
Journal:  Contemp Clin Trials       Date:  2010-03-20       Impact factor: 2.226

7.  Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Authors:  Lynne Penberthy; Richard Brown; Maureen Wilson-Genderson; Bassam Dahman; Gordon Ginder; Laura A Siminoff
Journal:  Clin Trials       Date:  2012-10-02       Impact factor: 2.486

8.  Recruitment of a racially and ethnically diverse sample into a physical activity efficacy trial.

Authors:  Georita M Frierson; David M Williams; Shira Dunsiger; Beth A Lewis; Jessica A Whiteley; Anna E Albrecht; John M Jakicic; Santina M Horowitz; Bess H Marcus
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

9.  Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study.

Authors:  Marilyn M Schapira; Elizabeth R Mackenzie; Regina Lam; David Casarett; Christina M Seluzicki; Frances K Barg; Jun J Mao
Journal:  Support Care Cancer       Date:  2013-12-21       Impact factor: 3.603

10.  Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials.

Authors:  Mona N Fouad; Aras Acemgil; Sejong Bae; Andres Forero; Nedra Lisovicz; Michelle Y Martin; Gabriela R Oates; Edward E Partridge; Selwyn M Vickers
Journal:  J Oncol Pract       Date:  2016-05-17       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.